January 19, 2017 5:45pm

 

Volatility takes its toll related directly to the sector’s credibility

 

Pre-open indication’s tally:  3 hit (AGTC, CYTX and PSTI) and 2 miss (BLCM and ONVO)

 

Out and about: Stemline Therapeutics (STML) proposes offering, no pricing or share amounts noticed.  STML closed DOWN -$0.70 with 133.7K volume <3 month average = 164.3 K>. Jefferies LLC is acting as book-running manager for the offering. Pluristem (PSTI) announces specifics of offering - a minimum of 8.16 M shares at a price to the public of $1.225 per share together with 50% warrants, HC Wainright is manager.

 

Can you afford to miss the insider view … Click here for access and subscribe:  http://www.regmedinvestors.com/create-account      

 


Members only. Please login.